PhRMA

Run a Compliant Speaker Program, Avoid Costly Penalties and Criminal Prosecution

By Gary Rom and Nicholas A. Klinefeldt You’ve likely heard of the $225 million global resolution opioid manufacturer Insys Therapeutics reached with the Department of Justice (DOJ) on June 5, 2019 to settle misconduct charges stemming from its speaker program practices. You’ve also likely thought that your company would never engage in the same behavior. […]